Skip to main content

Table 1 Baseline characteristics and risk factor analysis

From: Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India

Baseline characteristics

Risk factor analysis for abnormal and normal anal cytology in HIV positive men (n = 95)

Risk factor analysis for HPV positive and negative in HIV positive men (n = 119)

Frequency

Frequency

Uni-variate

Multi-variate

Frequency

Frequency

Uni-variate

No. (%)

No. (%)

No. (%)

No. (%)

Positive

(n = 60)

Negative

(n = 35)

OR

P-value

OR

P-value

Positive

(n = 33)

Negative

(n = 86)

OR

P-value

(95% CI)

(95% CI)

(95% CI)

Age (years)

< 35 year

27 (45.0)

18 (51.4)

0.7 (0.3–1.6)

0.54

  

15 (45.5)

41 (47.7)

0.9 (0.4–2.0)

0.82

33 (55.0)

17 (48.6)

1

18 (54.5)

45 (52.3)

1

Education

Illiterate

12 (20.0)

5 (14.3)

1.5 (0.4–4.6)

0.48

  

1 (3.0)

16 (18.6)

0.1 (0.0–1.0)

0.05

48 (80.0)

30 (85.7)

1

32 (97.0)

70 (81.4)

1

Employment

Unemployed

30 (50.0)

14 (40.0)

1.5 (0.6–3.4)

0.34

  

13 (39.4)

36 (41.9)

0.9 (0.3–2.0)

0.80

30 (50.0)

21 (60.0)

1

20 (60.6)

50 (58.1)

1

Urban/rural

Rural

45 (75.0)

26 (74.3)

0.9 (0.3–2.5)

0.93

  

26 (78.8)

61 (71.0)

0.6 (0.2–1.7)

0.38

15 (25.0)

9 (25.7)

1

7 (21.2)

25 (29.0)

1

Marital status

Married, Widowed, Divorced

6 (10.0)

1 (2.9)

0.2 (0.0–2.2)

0.22

  

6 (18.2)

4 (4.7)

0.2 (0.0–0.8)

0.22

Never married

54 (90.0)

34 (97.1)

1

   

27 (81.8)

82 (95.3)

1

 

History of active tuberculosis

Present

24 (40.0)

8 (22.9)

2.4 (1.1–6.1)

0.04

  

9 (27.3)

35 (40.7)

0.5 (0.2–1.3)

0.17

36 (60.0)

27 (77.1)

1

24 (72.7)

51 (59.3)

1

History of Alcohol intake

Yes

46 (76.7)

27 (77.1)

0.9 (0.3–2.6)

0.95

  

24 (72.7)

70 (81.4)

0.6 (0.2–1.5)

0.30

14 (23.3)

8 (22.9)

1

9 (27.3)

16 (18.6)

1

History of Smoking

Yes

48 (80.0)

28 (80.0)

1.0 (0.3–2.8)

0.99

  

26 (78.8)

72 (83.7)

0.7 (0.2–1.9)

0.52

12 (20.0)

7 (20.0)

1

7 (21.2)

14 (16.3)

1

History of Anal intercourse with other male.

Present

31 (51.7)

5 (14.3)

6.4 (2.1–18.7)

0.00*

6.1 (2.0–18.7)

0.00*

15 (45.5)

29 (33.7)

1.6 (0.7–3.7)

0.23

29 (48.3)

30 (85.7)

1

No. of Sexual partners

>one

50 (83.3)

27 (77.1)

1.5 (0.5–4.4)

0.39

  

26 (78.8)

70 (81.4)

0.8 (0.3–2.2)

0.74

10 (16.7)

8 (22.9)

1

7 (21.2)

16 (18.6)

1

History of hemorrhoid

Present

27 (45.0)

11 (31.4)

1.7 (0.7–4.2)

0.19

  

15 (45.5)

35 (40.7)

1.2 (0.5–2.7)

0.63

33 (55.0)

24 (68.6)

1

18 (54.5)

51 (59.3)

Anal symptoms (bleeding, discharge, pain, irritation)

Present

26 (43.3)

11 (31.4)

1.6 (0.6–4.0)

0.25

  

15 (45.5)

35 (40.7)

1.2 (0.5–2.8)

0.55

34 (56.7)

24 (68.6)

1

18 (54.5)

51 (59.3)

1

WHO HIV clinical staging

III + IV

30 (50.0)

9 (25.7)

2.8 (1.1–7.1)

0.02*

2.7 (1.1–7.5)

0.04*

14 (42.4)

37 (43.0)

0.9 (0.4–2.1)

0.95

I + II

30 (50.0)

26 (74.3)

1

   

19 (57.6)

49 (57.0)

1

 

CD4 count (ul)

(at the time of study)

< 350

50 (83.3)

22 (62.9)

2.9 (1.1–7.7)

0.02*

1.6 (0.5–4.7)

0.37

26 (78.8)

61 (71.0)

1.5 (0.5–3.9)

0.38

10 (16.7)

13 (37.1)

1

7 (21.2)

25 (29.0)

1

Weight (kg)

< 40

7 (11.7)

6 (17.1)

0.6 (0.1–2.0)

0.45

  

4 (12.1)

10 (11.6)

1.0 (0.3–3.6)

0.94

53 (88.3)

29 (82.9)

1

29 (87.9)

76 (88.4)

1

Hemoglobin (g/dl)

< 10 mg/dl

14 (23.3)

7 (20.0)

1.5 (0.5–4.3)

0.70

  

7 (21.2)

19 (22.0)

0.9 (0.3–2.5)

0.91

46 (76.7)

28 (80.0)

1

26 (78.8)

67 (78.0)

1

Presence of anal wart on visual inspection

Present

14 (23.3)

7 (20.0)

1.5 (0.5–4.3)

0.70

  

7 (21.2)

21 (24.4)

0.8 (0.3–2.1)

0.71

46 (76.7)

28 (80.0)

1

26 (78.8)

65 (75.6)

1

ART status

Pre ART

32 (53.3)

19 (54.3)

0.9 (0.4–2.2)

0.92

  

23 (69.7)

48 (55.8)

1.8 (0.7–4.2)

0.17

On ART

28 (46.7)

16 (45.7)

1

   

10 (30.3)

38 (44.2)

1